news
5-FU cream found to reduce the risk of squamous cell carcinoma
Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...
List view / Grid view
Drug delivery
news
Precision NanoSystems named as one of British Columbia’s fastest growing companies
Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journal Business in Vancouver (BIV)...
article
Formulation, Development & Delivery In-Depth Focus 2017
This In-Depth Focus examines water solubility for active ingredients, hot melt extrusion and designing appropriate non-clinical safety studies.
news
Heroin vaccine could tackle opioid addiction
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
product
Interview: Why is Data Integrity at the heart of the industry
How are you addressing risk management and data integrity...
article
Issue #6 2017 – Digital Version
This issue celebrates European Pharmaceutical Review's 21st birthday through 21 interviews with leading lights from across the pharmaceutical industry...
whitepaper
Application Note: A new crystallinity gauge: Real-time quantification and monitoring of crystallinity in pharmaceuticals
The measurement and quantification of crystallinity in pharmaceuticals is of vital importance, as this has a direct influence on the solubility and stability of the final drug product, affecting both efficacy and expiration...
whitepaper
Whitepaper: Do you know what’s going in? Analysing tablets by NIR spectroscopy
Drug analysis needs to be cost effective without compromising on accuracy...
whitepaper
Application Note: Elemental Impurities
Metallic contamination in drug products, referred to as elemental impurities, may arise from several sources...
whitepaper
Whitepaper: How an integrated development platform can meet the needs of both analytical development and QC teams
This whitepaper explains how an Integrated Development Platform can meet the needs of both analytical development and QC...
news
Niclosamide could lead the fight against Parkinson’s disease
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson's disease...
news
Abatacept improves survival in patients with acute GvHD
A drug used to treat rheumatoid arthritis improves survival after hematopoietic stem cell transplant...
article
Meeting access challenges with adaptive trial designs
With access challenges even after successful but costly development programmes, the industry is under pressure to speed up the clinical development process and produce more for less. Adaptive trial designs, more collaborative working and data sharing could provide a solution in the area of cancer immunotherapy, says Jacqueline Karmel, principal…
news
FDA approves first once-monthly buprenorphine injection for OUD
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
news
A risk factor for drug-induced skin disease identified
Researchers have identified a type of human leukocyte antigen (HLA) that is associated with the skin disease bullous pemphigoid (BP) in diabetic patients administered with DPP-4 inhibitory drugs.
